Polypyrrole solid phase microextraction: A new approach to rapid sample preparation for the monitoring of antibiotic drugs.
Simple or even rapid bioanalytical methods are rare, since they generally involve complicated, time-consuming sample preparation from the biological matrices like LLE or SPE. SPME provides a promising approach to overcome these limitations. The full potential of this innovative technique for medical diagnostics, pharmacotherapy or biochemistry has not been tapped yet. In-house manufactured SPME probes with polypyrrole (PPy) coating were evaluated using three antibiotics of high clinical relevance - linezolid, daptomycin, and moxifloxacin - from PBS, plasma, and whole blood. The PPy coating was characterised by scanning electron microscopy. Influences of pH, inorganic salt, and blood anticoagulants were studied for optimum performance. Extraction yields were determined from stagnant media as well as re-circulating human blood using the heart-and-lung machine model system. The PPy-SPME fibres showed high extraction yields, particularly regarding linezolid. The reproducibility of the method was optimised to achieve RSDs of 9% or 17% and 7% for SPME from stagnant or re-circulating blood using fresh and re-used fibres, respectively. The PPy-SPME approach was demonstrated to meet the requirements of therapeutic monitoring of the drugs tested, even from re-circulating blood at physiological flow rates. SPME represents a rapid and simple dual-step procedure with potency to significantly reduce the effort and expenditure of complicated sample preparations in biomedical analysis.
Szultka
Malgorzata
M
Department of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus, Copernicus University, Gagarin 7, 87-100 Torun, Poland.
Kegler
Ricarda
R
Fuchs
Patricia
P
Olszowy
Pawel
P
Miekisch
Wolfram
W
Schubert
Jochen K
JK
Buszewski
Boguslaw
B
Mundkowski
Ralf G
RG
D000081:Acetamides / Q000032:analysis / Q000097:blood / Q000302:isolation & purification; D000900:Anti-Bacterial Agents / Q000032:analysis* / Q000097:blood / Q000302:isolation & purification; D000925:Anticoagulants / Q000737:chemistry; D001372:Aza Compounds / Q000032:analysis / Q000097:blood / Q000302:isolation & purification; D002851:Chromatography, High Pressure Liquid; D017576:Daptomycin / Q000032:analysis / Q000097:blood / Q000302:isolation & purification; D024841:Fluoroquinolones; D006801:Humans; D006863:Hydrogen-Ion Concentration; D000069349:Linezolid; D000077266:Moxifloxacin; D023303:Oxazolidinones / Q000032:analysis / Q000097:blood / Q000302:isolation & purification; D011108:Polymers / Q000737:chemistry*; D011758:Pyrroles / Q000737:chemistry*; D011804:Quinolines / Q000032:analysis / Q000097:blood / Q000302:isolation & purification; D012492:Salts / Q000737:chemistry; D052617:Solid Phase Microextraction / Q000379:methods*
D000081:Acetamides; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D001372:Aza Compounds; D024841:Fluoroquinolones; D023303:Oxazolidinones; D011108:Polymers; D011758:Pyrroles; D011804:Quinolines; D012492:Salts; C067635:polypyrrole; D000069349:Linezolid; D017576:Daptomycin; D000077266:Moxifloxacin